Akebia Therapeutics (AKBA) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.1
-0.07
-0.03
0

Details

Expected EPS
-0.063333
Actual EPS
-0.1
Surprise EPS
-0.04
Surprise Percent
+57.9%

Description

Akebia Therapeutics (AKBA) has reported earnings of -0.1 per share for Q4 2024.

0 Comments

Share your thoughts